SK6042002A3 - High order nucleic acid based structures - Google Patents

High order nucleic acid based structures Download PDF

Info

Publication number
SK6042002A3
SK6042002A3 SK604-2002A SK6042002A SK6042002A3 SK 6042002 A3 SK6042002 A3 SK 6042002A3 SK 6042002 A SK6042002 A SK 6042002A SK 6042002 A3 SK6042002 A3 SK 6042002A3
Authority
SK
Slovakia
Prior art keywords
polynucleic acid
molecules
nucleic acid
dimensional
molecule
Prior art date
Application number
SK604-2002A
Other languages
English (en)
Slovak (sk)
Inventor
Frank J Carr
Graham Carter
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9926810.4A external-priority patent/GB9926810D0/en
Priority claimed from GB0011126A external-priority patent/GB0011126D0/en
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of SK6042002A3 publication Critical patent/SK6042002A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088Compounds having three or more nucleosides or nucleotides
    • A61K31/711Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/115Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/15Nucleic acids forming more than 2 strands, e.g. TFOs
    • C12N2310/151Nucleic acids forming more than 2 strands, e.g. TFOs more than 3 strands, e.g. tetrads, H-DNA
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/31Chemical structure of the backbone
    • C12N2310/315Phosphorothioates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/50Physical structure
    • C12N2310/52Physical structure branched

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SK604-2002A 1999-11-13 2000-11-13 High order nucleic acid based structures SK6042002A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9926810.4A GB9926810D0 (en) 1999-11-13 1999-11-13 High order nucleic acid-based structures
GB0011126A GB0011126D0 (en) 2000-05-10 2000-05-10 High order nucleic acid-based structures
PCT/EP2000/011197 WO2001036624A1 (en) 1999-11-13 2000-11-13 High order nucleic acid based structures

Publications (1)

Publication Number Publication Date
SK6042002A3 true SK6042002A3 (en) 2002-12-03

Family

ID=26244234

Family Applications (1)

Application Number Title Priority Date Filing Date
SK604-2002A SK6042002A3 (en) 1999-11-13 2000-11-13 High order nucleic acid based structures

Country Status (16)

Country Link
EP (1) EP1228201A1 (pl)
JP (1) JP2003522524A (pl)
KR (1) KR20020059727A (pl)
CN (1) CN1390253A (pl)
AU (1) AU782880B2 (pl)
BR (1) BR0015484A (pl)
CA (1) CA2391084A1 (pl)
CZ (1) CZ20021472A3 (pl)
HK (1) HK1052529A1 (pl)
HU (1) HUP0203914A2 (pl)
MX (1) MXPA02004727A (pl)
NO (1) NO20022231D0 (pl)
PL (1) PL358811A1 (pl)
RU (1) RU2002113755A (pl)
SK (1) SK6042002A3 (pl)
WO (1) WO2001036624A1 (pl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2487300A (en) 1998-12-31 2000-07-31 Chiron Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
EP1411770A4 (en) 2001-07-05 2006-05-10 Chiron Corp POLYNUCLEOTIDES CODING FOR ANTIGENIC C-TYPE HIV POLYPEPTIDES, POLYPEPTIDES AND THEIR USE
JP2014525921A (ja) * 2011-08-05 2014-10-02 プレジデント アンド フェローズ オブ ハーバード カレッジ 核酸ナノテクノロジー及びマイクロテクノロジーに関する組成物及び方法
WO2014018675A1 (en) 2012-07-24 2014-01-30 President And Fellows Of Harvard College Self-assembly of nucleic acid nanostructures
WO2014074597A1 (en) 2012-11-06 2014-05-15 President And Fellows Of Harvard College Compositions and methods relating to complex nucleic acid nanostructures
WO2015070080A2 (en) * 2013-11-08 2015-05-14 Dana-Farber Cancer Institute, Inc. Nucleic acid nanostructures for in vivo agent delivery
JP2017523594A (ja) 2014-05-22 2017-08-17 プレジデント アンド フェローズ オブ ハーバード カレッジ スケーラブルな核酸をベースにしたナノファブリケーション
EP3426598B1 (en) 2016-03-11 2021-07-28 Children's Medical Center Corporation Nucleic acid nanoswitch catenanes
EP3494124B1 (en) 2016-08-02 2022-03-09 President and Fellows of Harvard College Crisscross cooperative self-assembly
CN110711254B (zh) * 2018-07-12 2022-07-26 百药智达(北京)纳米生物技术有限公司 核酸纳米颗粒及包含其的药物组合物
TWI743518B (zh) * 2018-07-12 2021-10-21 大陸商百藥智達(北京)納米生物技術有限公司 核酸奈米顆粒、包含其的藥物組合物、含阿霉素的藥物及其製備方法
CN110960534B (zh) * 2018-09-30 2022-07-26 百药智达(北京)纳米生物技术有限公司 含五氟尿嘧啶的药物、其制备方法、药物组合物及其应用
CN110960536B (zh) * 2018-09-30 2022-07-26 百药智达(北京)纳米生物技术有限公司 含阿司匹林的药物、其制备方法、药物组合物及应用
CN110960530B (zh) * 2018-09-30 2022-07-22 百药智达(北京)纳米生物技术有限公司 含他克林的药物、其制备方法、药物组合物及其应用
CN110960542B (zh) * 2018-09-30 2022-07-26 百药智达(北京)纳米生物技术有限公司 含吡柔比星的药物、其制备方法、药物组合物及其应用
CN110960690B (zh) * 2018-09-30 2022-07-22 百药智达(北京)纳米生物技术有限公司 含表柔比星的药物、其制备方法、药物组合物及其应用
CN111053765B (zh) * 2018-10-16 2022-07-26 百药智达(北京)纳米生物技术有限公司 含紫杉醇的药物、其制备方法、药物组合物及应用
CN111068065B (zh) * 2018-10-22 2022-07-26 百药智达(北京)纳米生物技术有限公司 含奥沙利铂的药物、其制备方法、药物组合物及其应用
CN111084887B (zh) * 2018-10-23 2022-07-22 百药智达(北京)纳米生物技术有限公司 含黄酮的药物、其制备方法、药物组合物及应用
CN111096965B (zh) * 2018-10-29 2022-07-26 百药智达(北京)纳米生物技术有限公司 含双氢青蒿素的药物、其制备方法、药物组合物及其应用
US12268748B2 (en) 2019-04-10 2025-04-08 President And Fellows Of Harvard College Nucleic acid nanostructures crosslinked with oligolysine
WO2020247724A1 (en) 2019-06-07 2020-12-10 Dana-Farber Cancer Institute, Inc. Dna nanostructure-based vaccines

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0151631A1 (en) * 1983-08-03 1985-08-21 The Research Foundation Of State University Of New York Nucleic acid branched junctions with precisely defined migrational mobility
US5386020A (en) * 1991-01-10 1995-01-31 New York University Multiply connected, three-dimensional nucleic acid structures
US5278051A (en) * 1991-12-12 1994-01-11 New York University Construction of geometrical objects from polynucleotides
US6072044A (en) * 1996-04-26 2000-06-06 New York University Nanoconstructions of geometrical objects and lattices from antiparallel nucleic acid double crossover molecules

Also Published As

Publication number Publication date
KR20020059727A (ko) 2002-07-13
WO2001036624A1 (en) 2001-05-25
CN1390253A (zh) 2003-01-08
BR0015484A (pt) 2002-07-02
AU782880B2 (en) 2005-09-08
EP1228201A1 (en) 2002-08-07
HUP0203914A2 (en) 2003-03-28
MXPA02004727A (es) 2002-08-30
AU2000101A (en) 2001-05-30
CZ20021472A3 (cs) 2002-07-17
PL358811A1 (pl) 2004-08-23
RU2002113755A (ru) 2004-01-10
HK1052529A1 (zh) 2003-09-19
NO20022231L (no) 2002-05-10
JP2003522524A (ja) 2003-07-29
CA2391084A1 (en) 2001-05-25
NO20022231D0 (no) 2002-05-10

Similar Documents

Publication Publication Date Title
SK6042002A3 (en) High order nucleic acid based structures
Brown et al. Development of better aptamers: structured library approaches, selection methods, and chemical modifications
US11111495B2 (en) Method for generating aptamers with improved off-rates
US7179894B2 (en) Combinatorial selection of oligonucleotide aptamers
CN101809167B (zh) 产生具有改良的解离速率的适配体的方法
BRPI0417830B1 (pt) métodos para síntese de uma molécula compreendendo uma porção funcional operativamente ligada a um oligonucleotídeo de codificação
US20110082286A1 (en) Method for Generating Aptamers with Improved Off-Rates
JP2001504448A (ja) 核酸の鏡面対称選択および進化
PT1266025E (pt) Esqueletos proteicos para imitadores de anticorpos e outras proteínas de ligação
Kopylov et al. Combinatorial chemistry of nucleic acids: SELEX
KR20040018316A (ko) 스캐폴드 구조의 c-타입 렉틴 유사 도메인을 가지는단백질의 조합 라이브러리
AU2006292524A1 (en) Focused libraries, functional profiling, laser selex and deselex
JP2004515219A (ja) 調節可能な触媒活性な核酸
Lato et al. Screening chemical libraries for nucleic-acid-binding drugs by in vitro selection: a test case with lividomycin
RU2652952C1 (ru) Способ создания и селекции библиотеки модифицированных аптамеров
ZA200204728B (en) High order nucleic acid based structures.
JPH09154585A (ja) マイクロ遺伝子のランダム重合体作成方法
Gat et al. Template‐Directed Ligation: Towards the Synthesis of Sequence Specific Polymers
Polisky Progress towards Therapeutic Application of SELEX-derived Aptamers
AU2015249081A1 (en) Method for generating aptamers with improved off-rates
POLISKY Progress towards Therapeutic Application of SELEX-derived
Schürmann et al. Aptamer Adaptability: Utilizing Tumor Cell Surface Heterogeneity to Self-Select Appropriate Diagnostic and Therapeutic Agents
WO2005056794A2 (en) Agents for the regulation of transcription via zinc-finger proteins
GREEN et al. ligands that inhibit the interaction of vascular permeability

Legal Events

Date Code Title Description
FC9A Refused patent application